M. Kraus & Co’s Pfizer PFE Stock Holding History

M. Kraus & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$501K	Hold	17,839	–	–	0.15%	54
2025 Q4	$444K	Sell	17,839 -650	-4%	-$16.4K	0.12%	59
2025 Q3	$471K	Sell	18,489 -308	-2%	-$7.6K	0.13%	58
2025 Q2	$456K	Sell	18,797 -294	-2%	-$6.86K	0.13%	60
2025 Q1	$484K	Sell	19,091 -132	-0.7%	-$3.45K	0.15%	56
2024 Q4	$510K	Buy	19,223 +78	+0.4%	+$2.12K	0.15%	55
2024 Q3	$554K	Sell	19,145 -50	-0.3%	-$1.46K	0.16%	50
2024 Q2	$537K	Sell	19,195 -235	-1%	-$6.47K	0.16%	50
2024 Q1	$539K	Buy	19,430 +1,243	+7%	+$34.5K	0.16%	50
2023 Q4	$524K	Sell	18,187 -245	-1%	-$7.41K	0.17%	50
2023 Q3	$611K	Sell	18,432 -2,434	-12%	-$86.1K	0.22%	45
2023 Q2	$765K	Hold	20,866	–	–	0.26%	40
2023 Q1	$851K	Sell	20,866 -411	-2%	-$17.8K	0.3%	39
2022 Q4	$1.09M	Buy	21,277 +161	+0.8%	+$7.72K	0.4%	35
2022 Q3	$924K	Buy	21,116 +43	+0.2%	+$2.09K	0.39%	34
2022 Q2	$1.1M	Hold	21,073	–	–	0.43%	33
2022 Q1	$1.09M	Buy	21,073 +480	+2%	+$24.9K	0.37%	34
2021 Q4	$1.22M	Sell	20,593 -705	-3%	-$34.9K	0.39%	33
2021 Q3	$916K	Sell	21,298 -47	-0.2%	-$2.08K	0.33%	37
2021 Q2	$836K	Sell	21,345 -552	-3%	-$21.5K	0.3%	38
2021 Q1	$793K	Buy	21,897 +142	+0.7%	+$5.04K	0.31%	38
2020 Q4	$801K	Sell	21,755 -1,333	-6%	-$48.9K	0.33%	37
2020 Q3	$804K	Buy	23,088 +24	+0.1%	+$841	0.38%	34
2020 Q2	$716K	Buy	23,064 +817	+4%	+$27.8K	0.37%	35
2020 Q1	$689K	Sell	22,247 -16	-0.1%	-$545	0.42%	33
2019 Q4	$828K	Sell	22,263 -131	-0.6%	-$4.67K	0.41%	35
2019 Q3	$763K	Buy	22,394 +69	+0.3%	+$2.51K	0.41%	34
2019 Q2	$918K	Buy	22,325 +1,002	+5%	+$39.8K	0.51%	30
2019 Q1	$859K	Sell	21,323 -4	-0%	-$160	0.5%	30
2018 Q4	$883K	Sell	21,327 -158	-0.7%	-$6.56K	0.58%	30
2018 Q3	$898K	Sell	21,485 -105	-0.5%	-$4.04K	0.52%	31
2018 Q2	$743K	Sell	21,590 -290	-1%	-$9.91K	0.47%	33
2018 Q1	$737K	Sell	21,880 -268	-1%	-$9.21K	0.47%	32
2017 Q4	$761K	Sell	22,148 -105	-0.5%	-$3.58K	0.46%	33
2017 Q3	$754K	Hold	22,253	–	–	0.47%	34
2017 Q2	$709K	Sell	22,253 -1,001	-4%	-$31.6K	0.45%	35
2017 Q1	$755K	Sell	23,254 -1,165	-5%	-$36.7K	0.5%	35
2016 Q4	$752K	Sell	24,419 -851	-3%	-$26K	0.51%	35
2016 Q3	$812K	Sell	25,270 -625	-2%	-$20.9K	0.56%	36
2016 Q2	$865K	Hold	25,895	–	–	0.62%	35
2016 Q1	$728K	Hold	25,895	–	–	0.54%	37
2015 Q4	$793K	Sell	25,895 -369	-1%	-$11.6K	0.6%	35
2015 Q3	$783K	Hold	26,264	–	–	0.63%	37
2015 Q2	$836K	Sell	26,264 -596	-2%	-$19.4K	0.61%	36
2015 Q1	$887K	Sell	26,860 -1,653	-6%	-$52.6K	0.64%	36
2014 Q4	$843K	Sell	28,513 -194	-0.7%	-$5.56K	0.61%	36
2014 Q3	$805K	Sell	28,707 -63,490	-69%	-$1.78M	0.62%	35
2014 Q2	$2.6M	Sell	92,197 -743	-0.8%	-$21.2K	1.97%	31
2014 Q1	$2.83M	Sell	92,940 -210	-0.2%	-$6.26K	2.3%	25
2013 Q4	$2.71M	Buy	+93,150	New	+$2.71M	2.2%	28

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

M. Kraus & Co's PFE Position: Q1 2026 in Review

M. Kraus & Co held its Pfizer (PFE) position steady in Q1 2026 at 17,839 shares worth $501K. The position accounts for 0.15% of the portfolio, ranked #54.

M. Kraus & Co first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.83M in Q1 2014. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

M. Kraus & Co held 17,839 shares of Pfizer worth $501K as of Q1 2026.
M. Kraus & Co left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.15% of M. Kraus & Co's portfolio in Q1 2026, its #54 holding.
M. Kraus & Co first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
M. Kraus & Co's Pfizer position peaked at $2.83M in Q1 2014.
2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on M. Kraus & Co's 13F filing for Q1 2026, filed 14 Apr 2026.